Journal of the American College of Cardiology
Volume 63, Issue 12, Supplement, 1 April 2014, Page A325
Arrhythmias and Clinical EPCOMPARISON OF DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND VALVULAR HEART DISEASE: THE RE-LY® TRIAL
Under an Elsevier user license
open archive
Cited by (0)
Poster Contributions
Hall C
Saturday, March 29, 2014, 10:00 a.m.-10:45 a.m.
Session Title: Arrhythmias and Clinical EP: State of the Art Anticoagulation for Atrial Fibrillation
Abstract Category: 4. Arrhythmias and Clinical EP: AF/SVT
Presentation Number: 1109-115
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.